Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132452) titled 'Effect of Esketamine on Postoperative Fatigue and Recovery Quality in Patients Undergoing Hysterectomy' on Sept. 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second People's Hospital of Hefei
Condition:
Uterine Fibroids?Endometriosis?Adenomyosis?Uterine Prolapse?Uterine Malignancies
Intervention:
The esketamine group (Group S):Use an intravenous analgesia pump (2 µg/kg sufentanil + 8.96 mg tolterodine + 1 mg/kg esclorazepam + normal saline to a total volume of 100 mL), and administer 0.5 mg/kg esclorazepam during induction.
Recruitment Status: Recruiting
Phase: ...